Where Medical Science
Meets Strategic Excellence.
Syvantae is a specialist medical advisory firm delivering end-to-end science, strategy, and evidence solutions across Pharma, MedTech, Biotech, and Nutraceuticals.
About Syvantae
One Partner.
Four Domains.
End-to-End Impact.
Founded by Dr. Rahul Rathod, a physician-executive with over 25 years across AbbVie, Bayer, Dr. Reddy's, Mitra Biotech, Zydus, and Glenmark, Syvantae brings institutional-grade medical affairs expertise to every engagement.
We operate at the intersection of clinical science, regulatory intelligence, and commercial strategy — delivering bespoke advisory that is evidence-led, outcomes-oriented, and built around your organisation's specific needs.
Meet Dr. Rathod"Let's build something that matters for patients."
Dr. Rahul Rathod, MD · MBA — Chief Consultant & Founder
Pharma
MedTech / Biotech
Nutraceuticals
Cosmeceuticals
Database & Registry
What We Offer
Advisory Built Around Your Science
Flexible, scalable engagement models — from project-based sprints to multi-year strategic partnerships — delivering measurable clinical and commercial impact.
Pharma Advisory
Scientific launch strategy, lifecycle management, clinical evidence generation, and pipeline intelligence across NDA–Phase IV.
Learn moreMedTech & Biotech
Product need-gap analysis, clinical investigation strategy, IDE/IVD studies, and regulatory pathway development for devices and biologics.
Learn moreNutraceuticals & Cosmeceuticals
Claims strategy, ingredient science review, HCP adoption programmes, and FSSAI-aligned regulatory evidence development.
Learn moreDatabase & Registry
Real-world evidence strategy, registry architecture and design, statistical analysis, and clinical decision intelligence infrastructure.
Learn moreWhy Syvantae
Science-to-Strategy.
Evidence-to-Impact.
Institutional-Grade Expertise
25+ years at the intersection of clinical science and commercial strategy — across AbbVie, Bayer, Dr. Reddy's, Mitra Biotech, Zydus, and Glenmark in regional and global roles.
Evidence-Led, Not Theoretical
85+ peer-reviewed publications and 60+ clinical programmes underpin every strategy we build. We don't recommend without evidence.
Built Around Your Needs
From a defined four-week sprint to a two-year strategic partnership — our engagement models are designed for maximum flexibility and measurable impact.
Therapy Area Depth Across 10+ Domains
Diabetes, oncology, and beyond — with Phase I–IV study expertise, NDA/CTA submissions, and HEOR frameworks across India, Asia-Pacific, and global markets.
Our Track Record
Multi-fold evidence uplift and MSL & governance transformation — delivered at scale.
10+
Therapy Areas
4
Advisory Domains
3
Engagement Models
I–IV
Phase Coverage
Regional & global roles across India, Asia-Pacific — specialising in diabetes, oncology, and emerging therapy areas.
Engagement Models
Flexible. Scalable. Built Around Your Needs.
4–12 Weeks
Project-Based
Defined scope, timeline, and deliverables — ideal for product launches, study design, and strategy sprints.
Ideal for: Launches · Studies · Strategy sprints
12 Months
1-Year Retainer
Ongoing strategic advisory with monthly engagement and on-demand support to build your Medical Affairs capability.
Ideal for: Growing teams · MA capability building
24 Months
2-Year Strategic Partnership
Deep integration with your medical team for long-term evidence strategy and full lifecycle advisory.
Ideal for: Full lifecycle advisory
Ready to Build Something That
Matters for Patients?
Explore how Syvantae can support your medical affairs strategy, clinical evidence generation, or pipeline development.